{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:19:38Z","timestamp":1789507178323,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Drug Technologies"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.lfs.2020.117963","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T16:21:02Z","timestamp":1591892462000},"page":"117963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Virtual screening, ADME\/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19"],"prefix":"10.1016","volume":"256","author":[{"given":"Lorane Izabel da Silva","family":"Hage-Melim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Bruno","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayana Keyla Seabra","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Cristina Cardoso","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenir Cabral","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Barros","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzane Quintana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Pegrucci","family":"Barcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaque Ant\u00f4nio Galindo","family":"Francischini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Henrique Tomich de Paula","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117963_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(20)30419-0","article-title":"A distinct name is needed for the new coronavirus","volume":"395","author":"Jiang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117963_bb0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.lfs.2020.117963_bb0015","article-title":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)","author":"Li","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117963_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.lfs.2020.117963_bb0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.virusres.2014.05.026","article-title":"Coronavirus reverse genetic systems: infectious clones and replicons","volume":"189","author":"Almaz\u00e1n","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.lfs.2020.117963_bb0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2020.117963_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic","volume":"25","author":"Velavan","year":"2020","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.lfs.2020.117963_bb0040","article-title":"Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs","author":"Arya","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.lfs.2020.117963_bb0045","first-page":"1","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"4489","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117963_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/emp2.12081","article-title":"COVID-19: a review of therapeutics under investigation","author":"Crosby","year":"2020","journal-title":"Journal of the American College of Emergency Physicians Open"},{"key":"10.1016\/j.lfs.2020.117963_bb0055","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra \u03b1-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2020.117963_bb0060","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117963_bb0065","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.lfs.2020.117963_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.lfs.2020.117963_bb0075","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2020.117963_bb0080","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","author":"Qamar","year":"2020","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"10.1016\/j.lfs.2020.117963_bb0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/14756366.2013.805755","article-title":"Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory\u2013antimicrobial agents and their docking studies with COX-1\/COX-2 active sites","volume":"29","author":"Chandak","year":"2014","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.lfs.2020.117963_bb0090","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.1096361","article-title":"The many roles of computation in drug discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117963_bb0095","author":"Schr\u00f6dinger"},{"key":"10.1016\/j.lfs.2020.117963_bb0100","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2147\/DDDT.S108118","article-title":"Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants","volume":"10","author":"Ntie-Kang","year":"2016","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.lfs.2020.117963_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0300-483X(95)03190-Q","article-title":"Computer prediction of possible toxic action from chemical structure: an update on the DEREK system","volume":"106","author":"Ridings","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2020.117963_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10629369908039182","article-title":"Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR","volume":"10","author":"Greene","year":"1999","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.lfs.2020.117963_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drudis.2007.01.011","article-title":"Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches","volume":"12","author":"Eckert","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2020.117963_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci990316u","article-title":"Combinatorial preferences affect molecular similarity\/diversity calculations using binary fingerprints and Tanimoto coefficients","volume":"40","author":"Godden","year":"2000","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.lfs.2020.117963_bb0125","first-page":"1636","article-title":"New PPAR\u03b1\/\u03b3\/\u03b4 optimal activator rationally designed by computational methods","volume":"27","author":"Padilha","year":"2016","journal-title":"J. Braz. Chem. Soc."},{"issue":"7019","key":"10.1016\/j.lfs.2020.117963_bb0130","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries problems with virtual screening","volume":"432","author":"Shoichet","year":"2006","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.lfs.2020.117963_bb0135","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/cmdc.201700129","article-title":"Cannabinoid type 1 receptor (CB1) ligands with therapeutic potential for withdrawal syndrome in chemical dependents of Cannabis sativa","volume":"12","author":"Ferreira","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.lfs.2020.117963_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2019.107102","article-title":"In silico identification of natural products with anticancer activity using a chemo-structural database of Brazilian biodiversity","volume":"83","author":"Gal\u00facio","year":"2019","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2020.117963_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126793","article-title":"Virtual screening to identify potent sepiapterin reductase inhibitors","volume":"30","author":"Gao","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2020.117963_bb0150","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00213-011-2449-3","article-title":"Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders","volume":"219","author":"Fagherazzi","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2020.117963_bb0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drudis.2006.12.011","article-title":"Targeting structural flexibility in HIV-1 protease inhibitor binding","volume":"12","author":"Hornak","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2020.117963_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.117963_bb0165","first-page":"1","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","author":"Young","year":"2020","journal-title":"JAMA - Journal of the American Medical Association"},{"key":"10.1016\/j.lfs.2020.117963_bb0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.drudis.2007.12.007","article-title":"Computational toxicology in drug development","volume":"13","author":"Muster","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.lfs.2020.117963_bb0175","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.117963_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proceedings of the Japan Academy, Series B"},{"key":"10.1016\/j.lfs.2020.117963_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/dmp.2014.151","article-title":"Favipiravir: a new medication for the Ebola virus disease pandemic","volume":"9","author":"Nagata","year":"2015","journal-title":"Disaster Medicine and Public Health Preparedness"},{"key":"10.1016\/j.lfs.2020.117963_bb0190","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.lfs.2020.117963_bb0195","first-page":"1","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.lfs.2020.117963_bb0200","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","author":"Cortegiani","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.lfs.2020.117963_bb0205","first-page":"294","article-title":"Ocular toxicity of hydroxychloroquine","volume":"12","author":"Yam","year":"2006","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.lfs.2020.117963_bb0210","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1167\/iovs.14-16345","article-title":"Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea","volume":"56","author":"De Sisternes","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2020.117963_bb0215","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/00028896009344089","article-title":"The effects of continuous exposure of animals to ethanolamine vapor","volume":"21","author":"Weeks","year":"1960","journal-title":"Am. Ind. Hyg. Assoc. J."},{"key":"10.1016\/j.lfs.2020.117963_bb0220","article-title":"Insight derived from molecular docking and molecular dynamics simulations into the binding interactions between HIV-1 protease inhibitor s and SARS-CoV-2 3CLpro","author":"Sang","year":"2020","journal-title":"ChemRxiv"},{"key":"10.1016\/j.lfs.2020.117963_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jbic.2013.1030","article-title":"Molecular docking, DFT and ADME-toxicity studies on analogues of epigallocatechin gallate as SARS coronavirus 3CL protease inhibitors","volume":"2","author":"Singh","year":"2013","journal-title":"Journal of Bioinformatics and Intelligent Control"},{"key":"10.1016\/j.lfs.2020.117963_bb0230","author":"Fischer"},{"key":"10.1016\/j.lfs.2020.117963_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.lfs.2020.117963_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.lfs.2020.117963_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202000028","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds","author":"Ton","year":"2020","journal-title":"Mol Inform"},{"key":"10.1016\/j.lfs.2020.117963_bb0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2020.117963_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2394-7438.182723","article-title":"Apixaban: an oral anticoagulant having unique mechanism of action with better safety and efficacy profile","volume":"2","author":"Fazeel","year":"2016","journal-title":"MAMC Journal of Medical Sciences"},{"key":"10.1016\/j.lfs.2020.117963_bb0260","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.117963_bb0265","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIRCULATIONAHA.118.037955","article-title":"Efficacy and safety of Apixaban versus warfarin in patients with atrial fibrillation and extremes in body weight","volume":"139","author":"Hohnloser","year":"2019","journal-title":"Circulation"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052030713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052030713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T19:19:35Z","timestamp":1735413575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052030713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":53,"alternative-id":["S002432052030713X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117963","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual screening, ADME\/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117963"}}